Literature DB >> 34055213

Novel Thienopyrimidines as Acetyl-CoA Carboxylase Inhibitors for Treating Liver Diseases.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2021        PMID： 34055213      PMCID： PMC8155258          DOI： 10.1021/acsmedchemlett.1c00208

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  4 in total

Review 1.  Insights Into Metabolic Mechanisms and Their Application in the Treatment of NASH.

Authors:  Phillip J White; Manal F Abdelmalek
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-02-01

Review 2.  Targeting Lipid Metabolism in Liver Cancer.

Authors:  Malak Alannan; Hussein Fayyad-Kazan; Véronique Trézéguet; Aksam Merched
Journal:  Biochemistry       Date:  2020-10-02       Impact factor: 3.162

Review 3.  Hepatic steatosis and respiratory diseases: a new panorama.

Authors:  Alan Eduardo Botello-Manilla; Guillermo Nahúm López-Sánchez; Norberto Carlos Chávez-Tapia; Misael Uribe; Natalia Nuño-Lámbarri
Journal:  Ann Hepatol       Date:  2021-02-04       Impact factor: 2.400

Review 4.  Evolving Role for Pharmacotherapy in NAFLD/NASH.

Authors:  Suzanna L Attia; Samir Softic; Marialena Mouzaki
Journal:  Clin Transl Sci       Date:  2020-08-25       Impact factor: 4.689
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.